{"name":"ReCode Therapeutics","slug":"recode-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RCT2100","genericName":"RCT2100","slug":"rct2100","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"RCT2100","genericName":"RCT2100","slug":"rct2100","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5CMm5FMzYyVG91eTFMamliblE4OFAtb0lMQ0ZuZXowLVMwTzFseU0yaEpIVUV2bmlkcDJWTHgtc3p1SUFSSzNMQk05c3NFVWxnTTF2UUplbC12SjJaSU1KUUJGY1ZOYVBDWDRKUQ?oc=5","date":"2026-02-23","type":"pipeline","source":"labiotech.eu","summary":"Seven influential women in biotech in 2026 - labiotech.eu","headline":"Seven influential women in biotech in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNeFJyYVBieS1EbTdERDBEVGRTVkxjWG8yaHdsdVoySXd1WU5ZbmF2ZUR4Qjk5VjlVUVlaS1J1dlBPRzVKNmNYSjNneDFVeHd0LTN1dDhvMDlORVU2VUhVUGZ4cU9SOTJaMVNCNUZRMDZYbnowMjAxR2ZucHJHZzdWWTBJMExRWkxLWDZWWnlVdWNCQUdGczZ4cVlYSlpveHRReVlLeg?oc=5","date":"2025-11-18","type":"regulatory","source":"Cystic Fibrosis News Today","summary":"FDA clears next phase of RCT2100 clinical trial for cystic fibrosis - Cystic Fibrosis News Today","headline":"FDA clears next phase of RCT2100 clinical trial for cystic fibrosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxONy02cWRYc1Bfb20xVnl5NHcwT2xpYUp5dFROenBfZFFKNElRQzc3emItWTQ2OUZlNnl0ZTJiVFZjcDZOaHRoNTRISGYzQzQ0MHprVUlBOXVjdW1jUGxyVEQ1TUpRa1RQTlQ1V29md0lfckY2MldGOHNHcXd3U0x6Z3Q5NXJvajB5b1U0OVkwUExGWDJtaVVUOGJveEZJTVFiZ0VuWDY0c0dBeENlVDdrZGVBTTlrLWRqUS05SEMyR3dBZnVWS2lIT09QZjkwSWVlMVliXzJtbFV6dGRZLWIwR08yTklaNW9sd19yRFVPQXBQOGhwMnplendwMFhOMmpjMWphOS1PMHppbE0zNU1DNndERUc4d2xUWWJSZDFwTkVHOGM?oc=5","date":"2025-09-29","type":"pipeline","source":"businesswire.com","summary":"ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provides Corporate Update - businesswire.com","headline":"ReCode Therapeutics Announces Over $29 Million in Additional Financing to Advance Genetic Medicines Pipeline and Provide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNNlVEYThva3dBSGg2OEJFYU8yU1VaOUMtdFRJSFBBY3dOMENIZk5GYnVWa3JWR1BBVGl3Y0lnSkttNmFucXRHX0JVYW9WRF9mSWk3RjNEVWNRcVZsVkpuX0FLQWV2X28tUFd5SXdHNkhFMnl0MkgyOXZyUXFLbzllaGhnRElwNUhFZ0M2bGFCcV9YaXNzcVVCWmJZNHZFT3dfNFBPby1XaEo5SEQ2cFFR?oc=5","date":"2025-09-29","type":"trial","source":"endpoints.news","summary":"IO Biotech to run another study for cancer vaccine; Boehringer ends mid-stage IPF trial - endpoints.news","headline":"IO Biotech to run another study for cancer vaccine; Boehringer ends mid-stage IPF trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPS0h1RDlYdTJNdkd0enBkR1JzQnpMSUs2SVhvMkhtcDRvWGZuSE9UMDN3VWlLbDZhUDVzQTNtWkNkQTJGNE93d3pCOXF2dGVyRlEwdkVtMDcwVzBZamdkcWhkMmkzZ05QX2tMQ2FlcXZnV0xxc2UtQ3F2LW1pUncxWFYydlloT1c0SHNKV2JaaUVRWFZuRGlIbXkyV09ycVU?oc=5","date":"2025-06-13","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Top Five Privately Held Edited Therapy Companies - Genetic Engineering and Biotechnology News","headline":"Top Five Privately Held Edited Therapy Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNb2RrVkFEVTljVndDUF8zZjBHV09TNzRUN3lRSl96UkZTVU1VZHRXdnJKN2pIeUxLbk9vVExXaXRNdWtlNS1rY0V1YS11NGpwWEJteWtjSGJROU5jcHRPQVhvU18wYk56aFNsNHFUejNsZWFfREF1VEg4MDQzWndYNVFyQmx5SEhyU1FLTmJwQ0t3aVJiMHNRMFR2TjdVbHRKTkl0LUMwNE1LaFpLYlZ2eXByYmx3YzZnZ2U0VW5oZl9QNFpWcXhV?oc=5","date":"2025-05-06","type":"trial","source":"Fierce Biotech","summary":"Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program - Fierce Biotech","headline":"Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNQUZodDZza0dQWUNfSnZBaHhKRXlXcnA3ZXJPb3BNSEhjendUV0txUjZSUmdRb0JyRmNnVkVpcmQtNzJGdjkzcmVvNFJjSGxMbzhBRGVJSTRnYjIxRi1OMC1QaHE1dGdXT0IyOXF1TUU0dHN2b2N6VXh3Ml9EQXd2SnN3?oc=5","date":"2024-11-19","type":"pipeline","source":"Pharmaceutical Technology","summary":"ReCode to secure funds for cystic fibrosis gene correction treatments - Pharmaceutical Technology","headline":"ReCode to secure funds for cystic fibrosis gene correction treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPQ2JHQkl5LVljc3hVUFB1enFqc3BxR2s0NzdUbEduYlZhOEdNYkQ2Zk9wZ3R3SWppWlEyX3FEeU1kVGlfUnROWWFrcXdVZHkzd05yZ2dZbGRKUUJ2SEp1SWh3VS1TTDJURW1mMEs5VzN6bUJCaWEwQVlSNkVqU2hWX3RtUWlCaDhLZk5DTm1aNFNlVkN2WDM4OENXUUVISHJSQnN5QnRoN3JpVjk1N0FxQVpaZDMxMHdGUWtNbVpucUx4c0JIQXlSMFpZSmpzWjBEeV9RY05fREFwWUZhQ1BjUlF6NVN2U3Z0TjY1N1B3?oc=5","date":"2024-11-18","type":"pipeline","source":"respiratory-therapy.com","summary":"CF Foundation Invests $15M in ReCode to Develop Gene Editing Therapy - respiratory-therapy.com","headline":"CF Foundation Invests $15M in ReCode to Develop Gene Editing Therapy - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOZTl1eWVlQUo3cm1LSjVkQjEwMTk4VTAyaU8xQllrSG5DR0dMbFR6VlJ6ZktJc3M2TkZlbFRSMmREOWxoUk5JSDg5Uk9vUDhuVjhpTjREWWNraEtBWXBzZlAtMmRNVG91Sms1RHhidHNCbHdiczVxcEFWVmNTMTB3WmZYeHhWc2cwN0hqR2daQlUwM2JrekRMeEhlSQ?oc=5","date":"2024-02-15","type":"deal","source":"BioPharma Dive","summary":"Intellia, ReCode partner on genetic medicines for cystic fibrosis - BioPharma Dive","headline":"Intellia, ReCode partner on genetic medicines for cystic fibrosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1NSU9DWkRCVmV2LW1JQkxhOVhndGVZd2d4cUZVVVVpcjVjMExYVmZjRUFUWWtaRlNNUk9NLXdoWWEzTVhFNTlibk1jRV9hR1NlQzJZd2tUelJnV2h4clZKMmVvVFNMajB6MHlvZksxZ1g4Skk?oc=5","date":"2023-05-15","type":"pipeline","source":"BioSpace","summary":"ReCode–a New Contestant in the mRNA Race - BioSpace","headline":"ReCode–a New Contestant in the mRNA Race","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQd2NfNnRhY0phR3pqR0U0eGd6dXBCc0duY2NQWXRVTUh3TzQzaFgxeUZUQlpNUkxSdGRKR1FJWGhTTWlqRDdRc0psR2hLeVFKbHA0SGs5RG9sZjlyTTVRbFZBUGFYcXpydlZaMGN4ek5aRmRUV016SUU3OEl4T2N5Y2IyRGZ0eVhib1dkb0NwbHQ1YkVscTF3Q24zcUhLMEpkMk9UUEJnTVdHMXpxSzFTXzE4WDF5WlNiTWZwSF9oRWkwTUxJenA4UXFGZEhkSDJpZ05ZT2gyT2ZuY0dDWHNkOQ?oc=5","date":"2023-01-09","type":"deal","source":"Bayer","summary":"AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform - Bayer","headline":"AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPY1c5dXpqdDlwS2dBRGlheDNmVEZDRmlzNEx5Q3JoaXJlMDUxMmI1dnkyQUpoM3V4aC1rZ3Z0LVNxTUxNeEtYRktNYmZKejBqS09FNEpSRzJZREM3SklCVy1UeWttY01OMVhEUTBKZ0Q4NnNYa2kwTXdtTzByRmRBam5yV3VqZGxUQjhtQnZhb2dvcy1xVy15Z1lsU1FJb21UNXJjX3pQUGtGY0tUa19xZmRzUWZXWDBRTjBLLTlpZkpsbUU?oc=5","date":"2022-06-29","type":"pipeline","source":"Fierce Biotech","summary":"ReCode breaks the mold with $120M financing, bringing clutch of Big Pharmas along for ride - Fierce Biotech","headline":"ReCode breaks the mold with $120M financing, bringing clutch of Big Pharmas along for ride","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}